Asbestos textile production linked to malignant peritoneal and pleural mesothelioma in women: Analysis of 28 cases in Southeast China von Gao, Zhibin, Hiroshima, Kenzo, Wu, Xiaodong, Zhang, Jixian, Shao, Dichu, Shao, Huajiang, Yang, Hanqing, Yusa, Toshikazu, Kiyokawa, Takako, Kobayashi, Makio, Shinohara, Yasushi, Røe, Oluf D., Zhang, Xing, Morinaga, Kenji

Volltext

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma von Panou, Vasiliki, Gadiraju, Meghana, Wolin, Arthur, Weipert, Caroline M, Skarda, Emily, Husain, Aliya N, Patel, Jyoti D, Rose, Buerkley, Zhang, Shannon R, Weatherly, Madison, Nelakuditi, Viswateja, Knight Johnson, Amy, Helgeson, Maria, Fischer, David, Desai, Arpita, Sulai, Nanna, Ritterhouse, Lauren, Røe, Oluf D, Turaga, Kiran K, Huo, Dezheng, Segal, Jeremy, Kadri, Sabah, Li, Zejuan, Kindler, Hedy L, Churpek, Jane E

Volltext

Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry von Sandeck, Helmut P, Røe, Oluf D, Kjærheim, Kristina, Willén, Helena, Larsson, Erik

Volltext

Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium von Bjerner, Johan, Bratt, Ola, Aas, Kirsti, Albertsen, Peter C., Fosså, Sophie D., Kvåle, Rune, Lilja, Hans, Müller, Christoph, Müller, Stig, Stensvold, Andreas, Thomas, Owen, Røe, Oluf D., Vickers, Andrew, Walz, Jochen, Carlsson, Sigrid V., Oldenburg, Jan

Volltext

Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway von Robles, Ana I, Olsen, Karina Standahl, Tsui, Dana W T, Georgoulias, Vassilis, Creaney, Jenette, Dobra, Katalin, Vyberg, Mogens, Minato, Nagahiro, Anders, Robert A, Børresen-Dale, Anne-Lise, Zhou, Jianwei, Sætrom, Pål, Nielsen, Boye Schnack, Kirschner, Michaela B, Krokan, Hans E, Papadimitrakopoulou, Vassiliki, Tsamardinos, Ioannis, Røe, Oluf D

Volltext

Prediction of 6-year risk of bladder cancer using the HUNT Lung Cancer Risk Model in ever-smokers: A HUNT study von Røe, Oluf D., Nguyen, Olav Toai Duc, Fotopoulos, Yannis, Lagani, Vincenzo, Tsamardinos, Ioannis

Volltext

Improvement of lung cancer risk prediction adding SNPs to the HUNT Lung Cancer Model: A HUNT Study von Røe, Oluf D., Nguyen, Olav Toai Duc, Lakiotaki, Klio, Tsamardinos, Ioannis, Lagani, Vincenzo, Markaki, Maria

Volltext

Abstract 481: Utility of hCG as a biomarker of treatment response in advanced urothelial cancer: A population based series at Akershus University Hospital, Norway von Puco, Katarina, Bjerner, Johan, Müller, Stig, Lilleaasen, Gunder M., Husby, Haldor, Røed-Undlien, Mattias, Heinrich, Daniel, Dahl, Fredrik A., Røe, Oluf D., Oldenburg, Jan

Volltext

Long-term predictive value of serum PSA values obtained in clinical practice: Results from the Norwegian Prostate Cancer Consortium (NPCC) von Oldenburg, Jan, Bjerner, Johan Lars, Lilja, Hans, Aas, Kirsti, Fossa, Sophie D., Mueller, Christoph, Mueller, Stig, Thomas, Owen, Stensvold, Andreas, Walz, Jochen, Røe, Oluf D., Bratt, Ola, Carlsson, Sigrid V.

Volltext

Proteomics analysis discovers biomarkers in serum months to years before small cell lung cancer: The HUNT study von Nguyen, Olav Toai Duc, Markaki, Maria, Chatzipantsiou, Christina, Sharma, Animesh, Lagani, Vincenzo, Tsamardinos, Ioannis, Røe, Oluf D.

Volltext

DNA repair suppression and effect of cisplatin in mesothelioma and lung cancer cell lines von Røe, Oluf D., Chen, Wu, Zhi, Xiaofei, Chen, Duan, Chen, Yijiang

Volltext

Postoperative leukopenia as an independent prognostic factor in gastric cancer patients von Chen, Xiaofeng, Pei, Dong, Røe, Oluf D., Qian, Jing, Zhu, Fang, He, Shaohua, Qian, Yingying, Liu, Yiqian, Yin, Yongmei, Yongqian, Shu

Volltext

Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation von Szejniuk, Weronika Maria, McCulloch, Tine, Røe, Oluf Dimitri

Volltext

Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway von Robles, Ana I, Olsen, Karina Standahl, Tsui, Dana W T, Georgoulias, Vassilis, Creaney, Jenette, Dobra, Katalin, Vyberg, Mogens, Minato, Nagahiro, Anders, Robert A, Børresen-Dale, Anne-Lise, Zhou, Jianwei, Sætrom, Pål, Nielsen, Boye Schnack, Kirschner, Michaela B, Krokan, Hans E, Papadimitrakopoulou, Vassiliki, Tsamardinos, Ioannis, Røe, Oluf D

Volltext

Pemetrexed as first or second line in 112 danish patients von Panou, Vasiliki, Nielsen, Ida, Soerensen, Jens Benn, Roe, Oluf D.

Volltext

Serum microRNAs/enriched pathways in lung cancer 1-4 years before diagnosis: A pilot study from the HUNT Biobank, Norway von Roe, Oluf D., Markaki, Maria, Mjelle, Robin, Sætrom, Pål, Tsamardinos, Ioannis, Lagani, Vincenzo

Volltext

Exon 20-Mutated NSCLC: Extending the Data Set to Allow the Recognition of Potential Causes von van Zandwijk, Nico, Amos, Christopher I., Røe, Oluf Dimitri, Reid, Glen, Klebe, Sonja

Volltext

Preoperative Serum Soluble Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin Predict Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Valve Surgery... von Cao, Hailong, MD, PhD, Zhou, Qing, MD, Wu, Yanhu, MD, Li, Qingguo, MD, PhD, Røe, Oluf Dimitri, MD, PhD, Chen, Yijiang, MD, PhD, Wu, Zhong, MD, PhD, Wang, Dongjin, MD, PhD

Volltext

Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma von Røe, Oluf Dimitri, Szulkin, Adam, Anderssen, Endre, Flatberg, Arnar, Sandeck, Helmut, Amundsen, Tore, Erlandsen, Sten Even, Dobra, Katalin, Sundstrøm, Stein Harald

Volltext

Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the... von Nguyen, Olav Toai Duc, Fotopoulos, Ioannis, Markaki, Maria, Tsamardinos, Ioannis, Lagani, Vincenzo, Røe, Oluf Dimitri

Volltext